Edition:
India

G1 Therapeutics Inc (GTHX.OQ)

GTHX.OQ on NASDAQ Stock Exchange Global Select Market

34.11USD
12 Dec 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$34.11
Open
$34.50
Day's High
$35.00
Day's Low
$33.65
Volume
123,917
Avg. Vol
122,655
52-wk High
$69.23
52-wk Low
$18.45

Chart for

About

G1 Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing small-molecule therapies for the treatment of cancer. Its two clinical-stage candidates are trilaciclib (G1T28) and G1T38, which are potent, selective inhibitors of the validated kinase targets CDK4/6. Trilaciclib and G1T38... (more)

Overall

Beta: --
Market Cap(Mil.): $731.75
Shares Outstanding(Mil.): 28.29
Dividend: --
Yield (%): --

Financials

Earnings vs. Estimates